Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RYTM

Rhythm Pharmaceuticals Inc

May 29 • 04:00PM ET

88.32

-4.66 -5.01 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN KRYS INCY AXSM KYMR MDGL NUVL PTGX VKTX NBIX

| Held by: VTI VB IWM XBI VBK VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.14	Insider Own	3.17%	Shs Outstand	68.45M	Perf Week	-2.07%
Market Cap	6.05B	Forward P/E	-	EPS next Y	-0.74	Insider Trans	-1.60%	Shs Float	66.36M	Perf Month	7.55%
Enterprise Value	5.94B	PEG	-	EPS next Q	-0.81	Inst Own	105.86%	Short Float	12.48%	Perf Quarter	-4.76%
Income	-207.84M	P/S	27.87	EPS this Y	-1.25%	Inst Trans	0.47%	Short Ratio	9.87	Perf Half Y	-18.79%
Sales	217.16M	P/B	49.18	EPS next Y	76.52%	ROA	-48.90%	Short Interest	8.28M	Perf YTD	-17.49%
Book/sh	1.80	P/C	17.77	EPS next 5Y	-	ROE	-285.76%	52W High	122.20 -27.73%	Perf Year	42.73%
Cash/sh	4.97	P/FCF	-	EPS past 3/5Y	3.66% -0.46%	ROIC	-59.77%	52W Low	60.06 47.04%	Perf 3Y	441.18%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	100.23% -	Gross Margin	89.25%	Volatility	3.93% 5.14%	Perf 5Y	350.38%
Dividend TTM	-	EV/Sales	27.35	EPS Y/Y TTM	-11.45%	Oper. Margin	-90.89%	ATR (14)	4.28	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.89	Sales Y/Y TTM	58.67%	Profit Margin	-95.71%	RSI (14)	48.21	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	4.17	EPS Q/Q	-3.59%	SMA20	-2.33%	Beta	1.94	Target Price	138.20
Payout	-	Debt/Eq	1.85	Sales Q/Q	83.81%	SMA50	1.18%	Rel Volume	0.90	Prev Close	92.98
Employees	414	LT Debt/Eq	1.76	Earnings	May 05 BMO	SMA200	-10.43%	Avg Volume	839.31K	Price	88.32
IPO	Oct 05, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.96% 7.77%	Trades		Volume	755,822	Change	-5.01%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)